Pharmaron Beijing Co., Ltd.: what insiders have been doing
Headquartered in Beijing, People's Republic of China, Pharmaron Beijing Co., Ltd. belongs to the Health Care sector and traces its origins to 2004. Its latest reported headcount is 25,088 employees (2025). Filings by its managers are published through SSE / SZSE (CSRC). No insider at Pharmaron Beijing Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 19 September 2023.
The full history, which starts in 2022, counts no purchases against 5 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Analyst consensus: bullish or bearish?
Analysts rate Pharmaron Beijing Co., Ltd. Buy (bullish), based on 10 analysts. Average price target: CN¥50.44.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 667,900 shares57.3% of flowA股XSHESZSE:173000006948657950
- 15,700 shares2.1% of flowA股XSHESZSE:173000006672216220
- 50,000 shares12.2% of flowA股XSHESZSE:173000006202084100
- 30,000 shares100.0% of flowA股XSHESZSE:173000006202084030
- 150,000 shares28.5% of flowA股XSHESZSE:173000006136669820
5 of 5 declarations
About Pharmaron Beijing Co., Ltd.
康龙化成 is a company specializing in the healthcare and pharmaceutical sector, providing research and development services. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
